ouabain has been researched along with Cardiomyopathies in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (57.89) | 18.7374 |
| 1990's | 7 (36.84) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagrov, AY; Cooper, CJ; El-Okdi, N; Elkareh, J; Fedorova, OV; Gohara, S; Gupta, S; Haller, S; Malhotra, D; Periyasamy, SM; Shapiro, JI; Shidyak, A; Taleb, M; Tian, J; Xie, Z | 1 |
| DATLOW, DW; DEVITA, VT; GOOCH, AS; MASSUMI, RA; NUTTER, D; RIOS, JC | 1 |
| Alabaster, C; Barnes, P; Dollery, C; Karliner, JS; Stephens, H | 1 |
| Huang, BS; Leenen, FH; Yu, H; Yuan, B | 1 |
| De Pover, A; Gradoux, N; Grupp, G; Grupp, IL; Kremers, W; Lingrel, JB; Melvin, D; Shamraj, OI | 1 |
| Allen, PD; Alpert, NR; Hasenfuss, G; Just, H; Mulieri, LA | 1 |
| Bundgaard, H; Kjeldsen, K; Larsen, JS; Schmidt, TA | 1 |
| Bethke, T; Eschenhagen, T; Klimkiewicz, A; Kohl, C; Mehl, H; Mende, U; Meyer, W; Neumann, J; Rosswag, S; von der Leyen, H | 1 |
| Borgers, M; Ver Donck, L | 1 |
| Böhm, M; Erdmann, E; Schwinger, RH | 1 |
| Anversa, P; Capasso, JM; Olivetti, G | 1 |
| Kjeldsen, K; Nørgaard, A | 1 |
| Mascarenhas, DA; Rossner, KL | 1 |
| Brown, L; Erdmann, E; Näbauer, M | 1 |
| Gould, L; Lyon, AF | 1 |
| Brennan, FJ; Chiong, MA; McCans, JL; Parker, JO | 1 |
| Chidsey, CA; Ito, Y; Suko, J | 1 |
| Di Lieto, M; Ettinger, S; Gould, L; Lyon, AF; McGinn, FX | 1 |
| Abelmann, WH; Adler, LN; Federici, EE; Kawai, C; Yankopoulos, NA | 1 |
19 other study(ies) available for ouabain and Cardiomyopathies
| Article | Year |
|---|---|
Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufagenin.
Topics: Animals; Bufanolides; Canrenone; Cardiomyopathies; Cardiotonic Agents; Cells, Cultured; Disease Models, Animal; Drug Interactions; Endomyocardial Fibrosis; Fibroblasts; Mineralocorticoid Receptor Antagonists; Myocardium; Nephrectomy; Ouabain; Procollagen; Proline; Rats; Renal Insufficiency; Spironolactone; Tritium; Uremia | 2009 |
PRIMARY MYOCARDIAL DISEASE: REPORT OF FIFTY CASES AND REVIEW OF THE SUBJECT.
Topics: Alcoholism; Arrhythmias, Cardiac; Cardiac Catheterization; Cardiomegaly; Cardiomyopathies; Deficiency Diseases; Digitalis Glycosides; Drug Therapy; Electrocardiography; Embolism; Geriatrics; Heart Failure; Heart Function Tests; Hemodynamics; Humans; Kinetocardiography; Myocardium; Ouabain; Pathology; Phonocardiography; Radiography, Thoracic; Toxicology | 1965 |
Enhanced noradrenaline response in cardiomyopathic hamsters: possible relation to changes in adrenoceptors studied by radioligand binding.
Topics: Animals; Cardiomyopathies; Cricetinae; Heart Ventricles; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Myocardium; Norepinephrine; Ouabain; Receptors, Adrenergic | 1981 |
Brain 'ouabain' mediates sympathetic hyperactivity in congestive heart failure.
Topics: Animals; Brain; Brain Chemistry; Cardiomyopathies; Catecholamines; Cricetinae; Digoxin; Guanabenz; Heart Failure; Hemodynamics; Immunoglobulin Fab Fragments; In Vitro Techniques; Male; Myocardial Infarction; Myocardium; Ouabain; Rats; Rats, Wistar; Stress, Physiological; Sympathetic Nervous System | 1995 |
Characterisation of Na/K-ATPase, its isoforms, and the inotropic response to ouabain in isolated failing human hearts.
Topics: Blotting, Northern; Cardiomyopathies; Humans; Isoenzymes; Myocardial Contraction; Myocardium; Ouabain; RNA, Messenger; Sodium-Potassium-Exchanging ATPase; Stimulation, Chemical | 1993 |
Influence of isoproterenol and ouabain on excitation-contraction coupling, cross-bridge function, and energetics in failing human myocardium.
Topics: Cardiomyopathies; Energy Metabolism; Heart; Heart Failure; Heart Transplantation; Humans; In Vitro Techniques; Isoproterenol; Middle Aged; Myocardial Contraction; Myocardium; Ouabain; Thermodynamics | 1996 |
Reduced concentration of myocardial Na+,K(+)-ATPase in human aortic valve disease as well as of Na+,K(+)- and Ca(2+)-ATPase in rodents with hypertrophy.
Topics: 4-Nitrophenylphosphatase; Animals; Aortic Valve; Calcium-Transporting ATPases; Cardiomegaly; Cardiomyopathies; Cricetinae; Heart Valve Diseases; Humans; Mesocricetus; Myocardium; Ouabain; Rats; Rats, Inbred WKY; Sodium-Potassium-Exchanging ATPase | 1997 |
Phosphodiesterase inhibition by enoximone in preparations from nonfailing and failing human hearts.
Topics: Adult; Cardiomyopathies; Chromatography, DEAE-Cellulose; Enoximone; Female; Heart; Humans; Imidazoles; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocardium; Ouabain; Phosphodiesterase Inhibitors | 1992 |
Myocardial protection by R 56865: a new principle based on prevention of ion channel pathology.
Topics: Animals; Benzothiazoles; Calcium; Cardiomyopathies; Heart; Lysophosphatidylcholines; Myocardial Contraction; Ouabain; Oxygen; Piperidines; Rabbits; Rats; Singlet Oxygen; Sodium; Sodium Channels; Tetrodotoxin; Thiazoles; Veratridine | 1991 |
Effectiveness of cardiac glycosides in human myocardium with and without "downregulated" beta-adrenoceptors.
Topics: Adult; Cardiac Glycosides; Cardiomyopathies; Down-Regulation; Female; Heart; Heart Failure; Humans; In Vitro Techniques; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Ouabain; Papillary Muscles; Receptors, Adrenergic, beta; Sodium-Potassium-Exchanging ATPase | 1990 |
Mechanical and electrical properties of cardiomyopathic hearts of Syrian hamsters.
Topics: Action Potentials; Animals; Body Weight; Cardiomyopathies; Cricetinae; Disease Models, Animal; Electrolytes; Heart; Heart Rate; Membrane Potentials; Mesocricetus; Myocardial Contraction; Organ Size; Ouabain; Reference Values | 1989 |
The Na,K-pump in human myocardium: quantification in normal subjects and patients with suspected cardiomyopathy.
Topics: Cardiomyopathies; Humans; Kinetics; Myocardium; Ouabain; Protein Binding; Reference Values; Sodium-Potassium-Exchanging ATPase | 1988 |
The effect of ouabain on hearts of cardiomyopathic hamsters: potentiation by isoproterenol.
Topics: Animals; Cardiomyopathies; Cricetinae; Drug Synergism; Heart; Isoproterenol; Male; Myocardial Contraction; Ouabain; Papillary Muscles | 1987 |
Additive positive inotropic effects of milrinone, ouabain and calcium in diseased human ventricular myocardium.
Topics: Adult; Calcium; Cardiomyopathies; Cardiotonic Agents; Female; Heart Failure; Humans; Male; Middle Aged; Milrinone; Myocardial Contraction; Ouabain; Papillary Muscles; Pyridones; Rheumatic Heart Disease | 1986 |
Pulsus alternans. An early manifestation of left ventricular dysfunc- tion.
Topics: Adult; Arrhythmias, Cardiac; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiomegaly; Cardiomyopathies; Heart Ventricles; Humans; Male; Ouabain; Pulse | 1968 |
Effects of ouabain and diphenylhydantoin myocardial potassium balance in man.
Topics: Adenosine Triphosphatases; Aortic Valve Stenosis; Blood Pressure; Cardiac Output; Cardiomyopathies; Coronary Disease; Heart; Heart Rate; Heart Ventricles; Humans; Myocardium; Ouabain; Phenytoin; Potassium; Rheumatic Heart Disease; Sodium | 1973 |
Intracellular calcium and myocardial contractility. V. Calcium uptake of sarcoplasmic reticulum fractions in hypertrophied and failing rabbit hearts.
Topics: Animals; Azides; Biological Transport; Body Weight; Calcium; Calcium Radioisotopes; Cardiomyopathies; Electrocardiography; Fumarate Hydratase; Heart; Heart Failure; Mitochondria, Muscle; Muscle Proteins; Myocardium; Organ Size; Ouabain; Rabbits; Sarcoplasmic Reticulum; Succinate Dehydrogenase; Time Factors | 1974 |
The effect of stepwise doses of digitalis on hemodynamic function in man.
Topics: Administration, Oral; Animals; Cardiac Catheterization; Cardiac Output; Cardiomyopathies; Chagas Disease; Coronary Disease; Digitalis Glycosides; Digoxin; Dogs; Electrocardiography; Heart Diseases; Hemodynamics; Humans; Hypertension; Male; Mitral Valve Insufficiency; Ouabain; Oxygen Consumption; Phonocardiography | 1970 |
The hemodynamic effects of ouabain upon the diseased left ventricle.
Topics: Adult; Aortic Valve Stenosis; Arrhythmias, Cardiac; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiomyopathies; Female; Heart Conduction System; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Ouabain | 1968 |